A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients

Bell Gregory; Huang Saling; Martin Kevin J.; Block Geoffrey A.

首页> 外文期刊>Current medical research and opinion >A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients

【24h】

A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients

机译：一项随机，双盲，2期临床研究，评估AMG 416在血液透析患者中继发性甲状旁腺功能亢进的安全性和疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:

机译：目的：

著录项

来源
《Current medical research and opinion》 |2015年第5期|共10页
作者
Bell Gregory; Huang Saling; Martin Kevin J.; Block Geoffrey A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
AMG 416; Calcium-sensing receptor; Chronic kidney disease; Hemodialysis; Secondary hyperparathyroidism;

机译：AMG 416;钙敏感受体;慢性肾脏病;血液透析;继发性甲状旁腺功能亢进;

相似文献

外文文献
中文文献
专利

1. A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients [J] . Bell Gregory, Huang Saling, Martin Kevin J., Current medical research and opinion . 2015,第5期

机译：一项随机，双盲，2期临床研究，评估AMG 416在血液透析患者中继发性甲状旁腺功能亢进的安全性和疗效
2. A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients [J] . Yokoyama Keitaro, Fukagawa Masafumi, Shigematsu Takashi, Clinical nephrology . 2017,第2期

机译：一种12周的剂量升级的精体升级（ONO-5163 / AMG 416），一种新的静脉内钙化，用于日本血液透析患者的继发性甲状旁腺功能亢进症
3. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis [J] . Warady Bradley A., Iles Janet N., Ariceta Gema, Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2019,第3期

机译：一种随机，双盲，安慰剂对照研究，评估慢性肾病患者慢性肾病和继发性甲状旁腺功能亢进患者的肌钙网疗效和安全性接受透析
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Impact of Long-Term Intravenous Vitamin D on Parathyroid Hormone, Calcium, and Phosphorus in Hemodialysis Patients with Secondary Hyperparathyroidism. [D] . Sarkissian Pekacheki, Ivet. 2012

机译：长期静脉给予维生素D对继发性甲状旁腺功能亢进的血液透析患者甲状旁腺激素，钙和磷的影响。
6. A phase 3 multicentre randomized double-blind placebo-controlled parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416) a novel intravenous calcimimetic for secondary hyperparathyroidism in Japanese haemodialysis patients [O] . Masafumi Fukagawa, Keitaro Yokoyama, Takashi Shigematsu, -1

机译：一项三期多中心随机双盲安慰剂对照平行组研究用于评估新型静脉拟钙剂ecalccalcetide（ONO-5163 / AMG 416）对日本血液透析患者继发性甲状旁腺功能亢进的疗效和安全性
7. Faculty Opinions recommendation of Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study. [O] . Mariano Rodriguez, María E Rodríguez 2020

机译：教师意见建议Evocalcet（KHK7580），一种新型钙质，在日本患者中进行血液透析的患者：随机，双盲，安慰剂，剂量寻找研究。

A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients

摘要

著录项

相似文献

相关主题

期刊订阅